An Italian Man Injured by E-Cigarette Explosion, Lawyer Files Lawsuit to Investigate Product Safety Responsibility

Aug.04
A 25-year-old man in Italy was severely injured by an e-cigarette explosion and has filed a lawsuit against the Chinese manufacturer and Italian distributor, calling for the recall of potentially dangerous products.

Key points:

 

·A 25-year-old man in Italy was seriously injured by an e-cigarette explosion, leading the victim to file a legal lawsuit against the Chinese manufacturer and Italian distributor. 

 

·The explosion caused multiple injuries to the man's head and limbs.

 


【2Firsts News Flash】According to secolo on August 3, an e-cigarette explosion incident occurred in Rimini, Italy. A 25-year-old plumber experienced an unexpected explosion while using an e-cigarette, resulting in a head injury requiring 50 stitches, as well as burns on his hands and legs.

 

The accident occurred on the morning of July 31st when a young man, on his way to work, placed an e-cigarette in his pocket. Unexpectedly, the e-cigarette exploded, causing his left leg to catch on fire. In a panic, he tried to remove the burning device but fell to the ground due to pain and panic, hitting a cement flower pot and sustaining serious head injuries.

 

The injured were immediately transported to the hospital for treatment and were discharged after a ten-day recovery period. The e-cigarette involved in the incident was purchased at a store, and, although it was a Chinese product, it had CE certification.

 

The injured party's lawyer, Stefano Caroli, has filed a lawsuit with the Rimini Public Prosecutor's Office accusing Chinese products and Italian distributors, demanding an investigation into product certification. The lawyer also requested the court to seal similar products on the market that may pose safety hazards. Caroli stated that consumers must be warned of this potential danger.

 

This incident has sparked widespread concern about the safety of e-cigarettes and has prompted a further examination of the necessity to review products on the market.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

JUUL wins approval after FDA reversal of Marketing Denial Order
JUUL wins approval after FDA reversal of Marketing Denial Order
JUUL's regulatory journey from Marketing Denial Order to approval showcases FDA's evolving approach to e-cigarette oversight.
Nov.03 by 2FIRSTS.ai
Harm Reduction Experts Warn: FCTC COP11 Policies Risk Marginalizing the Global South
Harm Reduction Experts Warn: FCTC COP11 Policies Risk Marginalizing the Global South
Two global tobacco harm reduction experts, in their submission to 2Firsts, argue that several COP11 policy proposals driven by high-income countries do not align with the capacities and conditions of low- and middle-income countries. They highlight research and funding gaps and call for a more equitable global support mechanism.
Nov.19
 Number of Vapers in Britain Surpasses Smokers for the First Time, Government Tightens Nicotine Regulations
Number of Vapers in Britain Surpasses Smokers for the First Time, Government Tightens Nicotine Regulations
For the first time, more people in Britain now vape than smoke. According to the Office for National Statistics (ONS), 10% of adults (5.4 million) regularly use e-cigarettes compared with 9.1% (4.9 million) who smoke cigarettes. The government credits vaping for the decline in smoking but plans tougher rules through the Tobacco and Vapes Bill, including a generational smoking ban and restrictions on nicotine pouch flavours, packaging, and sales.
Nov.05 by 2FIRSTS.ai
84% of Britons Back Regulation of Nicotine Pouches, Survey Finds
84% of Britons Back Regulation of Nicotine Pouches, Survey Finds
A Northerner survey finds 84% of Britons support regulating nicotine pouches and 82% back a licensing scheme for vape sales, aligning with the Tobacco and Vapes Bill to improve consumer safety and youth protection.
Nov.06 by 2FIRSTS.ai
Elf Bar Parent iMiracle to Pull Flavored Vapes From California, Ending Altria Unit NJOY Lawsuit
Elf Bar Parent iMiracle to Pull Flavored Vapes From California, Ending Altria Unit NJOY Lawsuit
China’s e-cigarette maker iMiracle, parent company of the Elf Bar brand, has agreed to halt sales of all flavored vaping products in California as part of a settlement with Altria Group’s e-cigarette unit, NJOY LLC, marking the end of a nearly two-year legal dispute.
Oct.13
BAT Pauses U.S. Launch of Unlicensed Vuse One Vape amid FDA Crackdown — Reuters
BAT Pauses U.S. Launch of Unlicensed Vuse One Vape amid FDA Crackdown — Reuters
British American Tobacco has paused the U.S. pilot launch of its unlicensed Vuse One vape amid intensified FDA enforcement.
Oct.28 by 2FIRSTS.ai